258 related articles for article (PubMed ID: 18806270)
1. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
[TBL] [Abstract][Full Text] [Related]
2. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Ueda N; Tsuboi K; Uyama T
Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
[TBL] [Abstract][Full Text] [Related]
3. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
4. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
5. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tsuboi K; Takezaki N; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
Mulder AM; Cravatt BF
Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
[TBL] [Abstract][Full Text] [Related]
7. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.
Kaczocha M; Glaser ST; Chae J; Brown DA; Deutsch DG
J Biol Chem; 2010 Jan; 285(4):2796-806. PubMed ID: 19926788
[TBL] [Abstract][Full Text] [Related]
8. Effects of orthotopic implantation of rat prostate tumour cells upon components of the N-acylethanolamine and monoacylglycerol signalling systems: an mRNA study.
Alhouayek M; Stafberg L; Karlsson J; Bergström SH; Fowler CJ
Sci Rep; 2020 Apr; 10(1):6314. PubMed ID: 32286386
[TBL] [Abstract][Full Text] [Related]
9. Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.
Alhouayek M; Rankin L; Gouveia-Figueira S; Fowler CJ
Br J Pharmacol; 2019 May; 176(10):1470-1480. PubMed ID: 29313885
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.
Tsuboi K; Okamoto Y; Ikematsu N; Inoue M; Shimizu Y; Uyama T; Wang J; Deutsch DG; Burns MP; Ulloa NM; Tokumura A; Ueda N
Biochim Biophys Acta; 2011 Oct; 1811(10):565-77. PubMed ID: 21801852
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
Karlsson J; Gouveia-Figueira S; Alhouayek M; Fowler CJ
PLoS One; 2017; 12(9):e0185011. PubMed ID: 28910408
[TBL] [Abstract][Full Text] [Related]
12. Biosynthetic pathways of the endocannabinoid anandamide.
Okamoto Y; Wang J; Morishita J; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1842-57. PubMed ID: 17712822
[TBL] [Abstract][Full Text] [Related]
13. New players in the fatty acyl ethanolamide metabolism.
Rahman IA; Tsuboi K; Uyama T; Ueda N
Pharmacol Res; 2014 Aug; 86():1-10. PubMed ID: 24747663
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism.
Zhao LY; Tsuboi K; Okamoto Y; Nagahata S; Ueda N
Biochim Biophys Acta; 2007 Nov; 1771(11):1397-405. PubMed ID: 17980170
[TBL] [Abstract][Full Text] [Related]
17. A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells.
Sakura Y; Tsuboi K; Uyama T; Zhang X; Taoka R; Sugimoto M; Kakehi Y; Ueda N
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1951-1958. PubMed ID: 27693242
[TBL] [Abstract][Full Text] [Related]
18. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines.
Ueda N; Okamoto Y; Morishita J
Life Sci; 2005 Aug; 77(14):1750-8. PubMed ID: 15949819
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.
Brown I; Wahle KW; Cascio MG; Smoum-Jaouni R; Mechoulam R; Pertwee RG; Heys SD
Prostaglandins Leukot Essent Fatty Acids; 2011 Dec; 85(6):305-10. PubMed ID: 21995886
[TBL] [Abstract][Full Text] [Related]
20. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.
Bottemanne P; Muccioli GG; Alhouayek M
Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
